Accuray Incorporated (ARAY) - Total Assets

Latest as of December 2025: $448.01 Million USD

Based on the latest financial reports, Accuray Incorporated (ARAY) holds total assets worth $448.01 Million USD as of December 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. See Accuray Incorporated shareholders equity for net asset value and shareholders' equity analysis.

Accuray Incorporated - Total Assets Trend (2002–2025)

This chart illustrates how Accuray Incorporated's total assets have evolved over time, based on quarterly financial data.

Accuray Incorporated - Asset Composition Analysis

Current Asset Composition (June 2025)

Accuray Incorporated's total assets of $448.01 Million consist of 67.5% current assets and 32.5% non-current assets.

Asset Category Amount (USD) % of Total Assets
Cash & Equivalents $0.00 12.2%
Accounts Receivable $97.87 Million 20.8%
Inventory $141.02 Million 30.0%
Property, Plant & Equipment $0.00 0.0%
Intangible Assets $15.00K 0.0%
Goodwill $57.80 Million 12.3%

Asset Composition Trend (2002–2025)

This chart illustrates how Accuray Incorporated's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see market cap of Accuray Incorporated.

Key Asset Composition Facts

  • Current vs. Non-Current Assets: Accuray Incorporated's current assets represent 67.5% of total assets in 2025, an increase from 17.3% in 2002.
  • Cash Position: Cash and equivalents constituted 12.2% of total assets in 2025, down from 17.3% in 2002.
  • Tangible vs. Intangible: Intangible assets (including goodwill) make up 12.0% of total assets, an increase from 0.0% in 2002.
  • Asset Diversification: The largest asset category is inventory at 30.0% of total assets.

Accuray Incorporated Competitors by Total Assets

Key competitors of Accuray Incorporated based on total assets are shown below.

Company Country Total Assets
INKON Life Technology Co Ltd
SHE:300143
China CN¥4.15 Billion
CareRay Digital Medical Technology Co Ltd
SHG:688607
China CN¥988.48 Million
Senseonics Holdings, Inc. Common Stock
NYSE MKT:SENS
USA $139.92 Million
Universus Photo Imagings Limited
NSE:UNIVPHOTO
India Rs8.57 Billion
HansBiomed Corporation
KQ:042520
Korea ₩126.41 Billion
Aligned Genetics Inc
KQ:238120
Korea ₩45.11 Billion
Heramed Ltd
AU:HMD
Australia AU$1.04 Million
Acarix A/S
ST:ACARIX
Sweden Skr48.33 Million

Accuray Incorporated - Liquidity and Working Capital Analysis

Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.

Key Liquidity Metrics

Metric Current 1 Year Ago 5 Years Ago
Current Ratio 1.47 1.62 1.86
Quick Ratio 0.71 0.88 1.15
Cash Ratio 0.00 0.00 0.00
Working Capital $92.95 Million $124.44 Million $166.25 Million

Accuray Incorporated - Advanced Valuation Insights

This section examines the relationship between Accuray Incorporated's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.

Key Valuation Metrics

Current Price-to-Book Ratio 1.14
Latest Market Cap to Assets Ratio 0.11
Asset Growth Rate (YoY) 0.3%
Total Assets $470.24 Million
Market Capitalization $53.27 Million USD

Valuation Analysis

Below Book Valuation: The market values Accuray Incorporated's assets below their book value (0.11x), which may indicate investor concerns about asset quality or future growth.

Positive Asset Growth: Accuray Incorporated's assets grew by 0.3% over the past year, showing continued investment in the company's operational capacity.

Annual Total Assets for Accuray Incorporated (2002–2025)

The table below shows the annual total assets of Accuray Incorporated from 2002 to 2025.

Year Total Assets Change
2025-06-30 $470.24 Million +0.34%
2024-06-30 $468.63 Million -2.21%
2023-06-30 $479.21 Million +1.35%
2022-06-30 $472.85 Million -1.51%
2021-06-30 $480.10 Million -2.21%
2020-06-30 $490.93 Million +12.04%
2019-06-30 $438.18 Million +15.70%
2018-06-30 $378.73 Million -6.82%
2017-06-30 $406.46 Million -13.34%
2016-06-30 $469.03 Million -0.20%
2015-06-30 $469.97 Million -5.09%
2014-06-30 $495.19 Million +4.05%
2013-06-30 $475.93 Million +0.58%
2012-06-30 $473.17 Million +3.81%
2011-06-30 $455.78 Million +73.18%
2010-06-30 $263.18 Million -4.08%
2009-06-30 $274.39 Million -6.99%
2008-06-30 $295.00 Million -11.17%
2007-06-30 $332.11 Million +139.58%
2006-06-30 $138.62 Million +59.59%
2005-06-30 $86.86 Million +168.53%
2003-06-30 $32.35 Million +171.25%
2002-06-30 $11.93 Million --

About Accuray Incorporated

NASDAQ:ARAY USA Medical Devices
Market Cap
$53.27 Million
Market Cap Rank
#21663 Global
#4603 in USA
Share Price
$0.47
Change (1 day)
+0.66%
52-Week Range
$0.34 - $1.85
All Time High
$7.46
About

Accuray Incorporated engages in the design, development, manufacture, and sale of radiosurgery and radiation therapy systems for the treatment of tumors in the United States, Canada, Latin America, Asia, Australia, New Zealand, Europe, the Middle East, India, Africa, Japan, and China. The company offers the CyberKnife platform, a robotic stereotactic radiosurgery and stereotactic body radiation t… Read more